Autologous bone marrow-derived mononuclear cell transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous bone marrow-derived mononuclear cell transplantation, covering 2024-10-01 to 2024-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae [Phase 1, Phase 2]